IO Biotech Inc (NASDAQ: IOBT) on Monday, plunged -20.28% from the previous trading day, before settling in for the closing price of $0.83. Within the past 52 weeks, IOBT’s price has moved between $0.32 and $2.79.
Annual sales at Healthcare sector company slipped by -25.33% over the past five years. The company achieved an average annual earnings per share of 21.79%. With a float of $46.66 million, this company’s outstanding shares have now reached $69.69 million.
IO Biotech Inc (IOBT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of IO Biotech Inc is 29.17%, while institutional ownership is 40.76%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.46 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.38) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.70% during the next five years compared to -25.33% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
IO Biotech Inc (IOBT) is currently performing well based on its current performance indicators. A quick ratio of 2.01 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
IO Biotech Inc (NASDAQ: IOBT) saw its 5-day average volume 1.01 million, a negative change from its year-to-date volume of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 16.56%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 13.64%, which indicates a significant increase from 6.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1080 in the past 14 days, which was lower than the 0.1729 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0117, while its 200-day Moving Average is $1.2308. Nevertheless, the first resistance level for the watch stands at $0.7828 in the near term. At $0.9057, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9815. If the price goes on to break the first support level at $0.5841, it is likely to go to the next support level at $0.5083. The third support level lies at $0.3854 if the price breaches the second support level.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
Market capitalization of the company is 43.47 million based on 65,880K outstanding shares. Right now, sales total 0 K and income totals -95,490 K. The company made 0 K in profit during its latest quarter, and -26,220 K in sales during its previous quarter.
